NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/24/2025
Back to search
Official data from USPTO
CARTREVIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARTREVIVE
ST13
US500000079365432Class
5, 10, 44
Filing
79365432
Registration
7369778
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/25/2025
Trademark type
Word
Nice classes
5, 10, 44
Filing date
09/14/2022
Registration date
04/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
10/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
NL
Examiner
FRENCH,CURTIS W
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Hy2Care B.V.
Representatives
Bradley M. Stohry Reichel Stohry Dean LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human body for cartilage repair and treatments; medicated hydrogels resorbable by the human body for pain management and inflammation reduction; medicated hydrogels resorbable by the human body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillersteeth filling material; surgical glues and sealants
Class 10
Medical devicesinjection needles; medical devicessyringes; medical devices for injection of liquid components in the human bodyinjection needles; medical devices for injection of liquid polymers in the human bodyinjection needles; medical devices for injection of hydrogels in the human bodyinjection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human bodyinjection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human bodyinjection instruments with needles; medical devices for supply of dermal fillers to the human body; medical devices for supply of dental fillers to the human bodyinjection needles; medical devices for supply of dental fillers to the human bodysyringes; medical devices for application of surgical glues and sealants to the human body; diagnostic apparatus for medical purposesultrasound diagnostic apparatus; diagnostic apparatus for medical purposesX-ray diagnostic apparatus; cell culture instruments for medical usecell culture chambers
Class 44
Medical servicescartilage repair in the human body; medical servicespain management and inflammation reduction in the human body; medical servicesbone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment servicessurgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogels
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/21/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/21/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/21/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/21/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/21/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/29/2024
FIMP
FINAL DISPOSITION PROCESSED
10/28/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2024
PUBO
PUBLISHED FOR OPPOSITION
02/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/24/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2023
RFNT
REFUSAL PROCESSED BY IB
08/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/13/2023
RFRR
REFUSAL PROCESSED BY MPU
07/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/08/2023
CNRT
NON-FINAL ACTION WRITTEN
06/07/2023
DOCK
ASSIGNED TO EXAMINER
06/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/20/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/16/2023
Continuous trademark protection
Get notified about every new filing that threatens CARTREVIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.